Qasim Rizvi Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Qasim Rizvi is Chief Commercial Officer of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 5,176 shares of KNSA, which is worth approximately $103,571. The most recent transaction as insider was on Dec 31, 2020, when has been sold 2,161 shares (Class A Common Share) at a price of $17.67 per share, resulting in proceeds of $38,185. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.18K
0% 3M change
0% 12M change
Total Value Held $103,571

Qasim Rizvi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2020
SELL
Payment of exercise price or tax liability
$38,185 $17.67 p/Share
2,161 Reduced 29.45%
5,176 Class A Common Share
Dec 31 2020
BUY
Exercise of conversion of derivative security
-
7,337 Added 50.0%
7,337 Class A Common Share
QR

Qasim Rizvi

Chief Commercial Officer
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA